The idea in one paragraph
Standard semaglutide plans climb toward a target dose over months. A microdose plan holds a lower weekly amount on purpose. Nothing about the molecule changes – only how much of it you take.
What semaglutide does at any dose
According to FDA prescribing information, semaglutide is a GLP-1 receptor agonist. It engages the same receptor pathway your gut uses after a meal, which participates in fullness and in how quickly the stomach empties. A smaller amount engages fewer receptors.
Why people ask for it
Tolerability is the most common reason – some people find higher doses uncomfortable. Others want a gentler start, or want to hold steady rather than escalate. Whether that suits you is a clinical judgement, not a menu choice.
Trial results belong to the specific FDA-approved product studied, at the doses studied.
What the evidence covers
STEP 1, published in the New England Journal of Medicine, studied the FDA-approved brand product at the doses in its protocol. It did not evaluate microdose schedules or compounded preparations. Results reported there describe the studied product only.
Being straight about the unknowns
No published trial establishes what a microdose achieves, and no result is promised. Side effects can occur at any dose. Anything persistent or severe goes to your clinician, not to a forum.
Cost and how to start
Compounded semaglutide microdose is $179 per 4 weeks here, cash pay, no insurance billed. The intake takes about ten minutes, a clinician can decline, and you are refunded in full if nothing is prescribed. See the 30-second film answers for this medication.
A compounded preparation is not a generic of, or equivalent to, any FDA-approved product.
What a titration schedule is actually for
Titration means starting at a dose below the one intended to be effective and stepping up on a schedule. It exists for tolerability, not caution for its own sake. Receptor signalling that arrives gradually gives the gut time to adapt, which is why the label sets minimum intervals between increases rather than leaving the pace open. Skipping ahead does not accelerate anything except side effects. Holding at a dose is a legitimate clinical decision, and so is stepping back down. If you want the lower end of that range as a deliberate plan rather than a waypoint, that is what microdosing describes. Your clinician sets the schedule, reviews how you are tolerating it, and adjusts. Nothing about a titration plan guarantees a particular result, and no schedule substitutes for the follow-up conversation that decides whether to continue.
How semaglutide works on the GLP-1 receptor
Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
Ten minutes now, and a licensed clinician tells you where you actually stand.
Frequently asked questions
Is this the same as a starter dose?
No. A starter dose is the first step of a schedule designed to climb. A microdose plan is intended to stay lower rather than titrate up on the standard timeline.
Is compounded semaglutide FDA-approved?
No. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
Does a lower dose still work?
No outcome is promised at any dose. What a lower dose is likely to do for you is a conversation with the clinician who reviews your case.
Can I choose my own dose?
No. The prescribing clinician sets the dose, and your dispensed label governs it.
How do I inject semaglutide?
Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.
Where do you inject semaglutide?
Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.
Ask a clinician about a low-dose plan
Complete an online intake and a licensed clinician reviews it. Rx only, and only if appropriate.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA prescribing information, semaglutide (DailyMed)
- Peer-reviewedWilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002
- FDAFDA. Compounding and the FDA: questions and answers
- FDA databaseDrugs@FDA: search approved labeling for semaglutide
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on GLP-1 Microdosing
Same medication, different question.
